The U.S. Cell-based Assays Market is projected to grow from USD 3.44 Billion in 2025 to USD 7.31 Billion by 2035, while ...

This article explores the causes of high-throughput screening assay failures, how these failures manifest in screening ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...

SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory ...

CAR-T-cell therapy has shown remarkable promise in addressing unmet medical needs in people with cancer. Continued progress in this field will depend, in part, on the advancement of frameworks for ...

Telomerase reverse transcriptase is crucial for cellular development, regeneration, and disease processes. Strategies for both telomerase activation and inhibition have been intensively explored in ...

From axolotls to zebrafish, stem cells possess remarkable regenerative abilities, enabling them to restore lost limbs and repair damaged organs. These extraordinary capabilities, however, are not ...

Potency assays are essential for product quality and patient safety. These tests enable a direct measurement of a biologic's functional activity, verifying that the therapy works as intended. Potency ...

Join Dr. Mikael Kubista, a pioneer of developing and standardizing real-time quantitative PCR (qPCR) and digital PCR (dPCR) assays for research and diagnostics. As a member of the American Association ...

Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...